This page keeps track of new/upcoming treatment options for Lyme disease (LD) and post-treatment Lyme disease syndrome (PTLDS). What’s in development? What’s promising? What’s available soon? Find out below… Current topics include azlocillin, cefotaxime, VLA15, disulfiram, acetogenins, and more.
SubscribeLast updated:
News
- A 360-Degree Approach to Lyme Disease: Harvard Medical School has received a $5 million gift for Lyme disease research and education Jul 2, 2020
- Lyme disease bacteria eradicated by new drug in early tests Mar 30, 2020
- Scientists find promising new treatment for Lyme disease that involves the drugs cefotaxime and azlocillin Mar 25, 2020
- Stanford scientists discover potential treatment for Lyme disease: azlocillin kills bacteria that may cause lingering symptoms, study finds Mar 12, 2020
- New act allots $150 million in federal funds to fight tick-borne diseases Dec 31, 2019
- Sen. Collins’ bill devoting $100 million to fight Lyme disease included in budget Dec 17, 2019
- ‘No one wanted to touch it’: Why a Lyme disease vaccine has been so elusive Dec 16, 2019
- Antibody shows promise in fight against Lyme disease Nov 23, 2019
- Father bedbound by Lyme disease is back on his feet due to a drug for alcoholism Nov 22, 2019
- New Breakthrough in Lyme Disease Testing Reduces Time to Results From Days to Minutes Nov 12, 2019
- Doctors Working On Possible Breakthrough Vaccine Against Disease-Carrying Ticks, Lyme Disease Oct 17, 2019
- Progress in New Ionica Sciences Lyme Disease Diagnostic Test Funded by Global Lyme Alliance (GLA) Sep 18, 2019
- Rapid Lyme test developed at Cornell could be ‘major breakthrough’ in treatment Sep 10, 2019
- Rapid Lyme disease test may be available in late 2020 Sep 4, 2019
- An innovative new diagnostic for Lyme disease: early detection method pinpoints molecular signatures of the disease with high accuracy Aug 26, 2019
- UK Lyme disease cases may be three times higher than estimated Jul 31, 2019
- The Challenge of Diagnosing Lyme Disease Jul 29, 2019
- Global Lyme Alliance (GLA) Opens Competition for 2019-20 Lyme Disease Research Grants Applications Jul 15, 2019
- Research offers possible clues about persistent Lyme disease Jun 18, 2019
- Breakthrough in Detecting Lyme Disease Could Lead to Better Treatment Jun 17, 2019
- Global Lyme Alliance (GLA) Awards $2 Million in Scientific Research Grants for 2019 Jun 4, 2019
- More Ticked Off – The Growing Threat of Lyme and Tick-Borne Diseases May 29, 2019
Research
- Azlocillin can be the potential drug candidate against drug-tolerant Borrelia burgdorferi sensu stricto JLB31 Mar 2, 2020
- Evidence that metabolic pathways can be used to mark the progression of early Lyme disease Dec 10, 2019
- BBE31 from the Lyme disease agent Borrelia burgdorferi shows the ability to bind glutathione: potentially opening doors to new strategies to fight against Lyme disease Nov 27, 2019
- Membrane directed expression in Escherichia coli of BBA57 and other virulence factors from the Lyme disease agent Borrelia burgdorferi Nov 26, 2019
- A novel laminin-binding protein mediates microbial-endothelial cell interactions and facilitates dissemination of Lyme disease pathogens Nov 23, 2019
- Appropriate laboratory testing in Lyme disease Nov 1, 2019
- Characterization of 5′-methylthioadenosine/S-adenosylhomocysteine nucleosidases from Borrelia burgdorferi: Antibiotic targets for Lyme disease Oct 31, 2019
- Combatting Lyme disease myths and the “chronic Lyme industry” Oct 7, 2019
Clinical Trials
- A Novel Nutraceutical to Combat Post-Lyme Disease Syndrome (PLDS) Dec 2, 2019
- Treating Post-Lyme Disease Syndrome With Acetogenins Nov 21, 2019
- Disulfiram: A Test of Symptom Reduction Among Patients With Previously Treated Lyme Disease Oct 30, 2019
- Alternative Schedule Study For VLA15, a Vaccine Candidate Against Lyme Borreliosis Oct 3, 2019
- Immunogenicity and Safety Study of VLA15, A Multivalent Recombinant OspA (Outer Surface Protein A) Based Vaccine Candidate Against Lyme Borreliosis Oct 1, 2019
- Different Amoxicillin Treatment Regimens in Erythema Migrans Patients Sep 30, 2019
- Inflammatory Mediators in Erythema Migrans May 20, 2019
- Detection of Borrelia Bacteria in Early Stage Lyme Borreliosis Using the T2Lyme Panel May 6, 2019
- Study Assessing the Safety, Immunogenicity and Dose Response of VLA15, A New Vaccine Candidate Against Lyme Borreliosis [Completed] Feb 27, 2019
- An Intervention in a Primary Healthcare Setting to Reduce Lyme Neuroborreliosis Treatment Delay (NBdelay) Jan 31, 2019
- Six Versus Two Weeks Treatment With Doxycycline in Lyme Neuroborreliosis Dec 18, 2018
